YD Bio Limited Warrants (YDESW)
Stock · NASDAQ · Health Care
$0.599as of 10/15/2026
Price chart
Active signals
High Beta21.2%
Support level
$0.365894
Industry
Medical Specialities
About YDESW
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate sym…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 13
Fundamentals
- 1-day range
- Market cap
- $16.29M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- 1.35
- Avg. volume
- —
52-week range
$0.1904$2.5
YD Bio Limited Warrants Competitors
Chosen by industry and closest market cap.
- YDESWYD Bio Limited Warrants$0.599▼ 9.24%Market cap $16.29MP/E —$0.1904$2.5
- ADVBAdvanced Biomed Inc. Common Stock$3.98▼ 18.44%Market cap $12.29MP/E 1.53$3.61$24.23
- MDXHMDxHealth SA Ordinary Shares$0.207▼ 65.73%Market cap $22.50MP/E —$0.4$5.33
- AMSAmerican Shared Hospital Services Common Stock$1.28▲ 1.59%Market cap $9.67MP/E —$1.21$2.39
- ACONAclarion Inc. Common Stock$1.85▼ 5.27%Market cap $5.79MP/E —$1.89$9.38
- BGLCBioNexus Gene Lab Corp Common stock$1.2▼ 1.64%Market cap $3.82MP/E —$1.07$5.89
- SERASera Prognostics Inc. Class A Common Stock$2.06▲ 1.48%Market cap $78.32MP/E —$1.56$3.95
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| YDESW YD Bio Limited Warrants | $16.29M | — | $0.599 | ▼ 9.24% | $0.1904$2.5 |
| ADVB Advanced Biomed Inc. Common Stock | $12.29M | 1.53 | $3.98 | ▼ 18.44% | $3.61$24.23 |
| MDXH MDxHealth SA Ordinary Shares | $22.50M | — | $0.207 | ▼ 65.73% | $0.4$5.33 |
| AMS American Shared Hospital Services Common Stock | $9.67M | — | $1.28 | ▲ 1.59% | $1.21$2.39 |
| ACON Aclarion Inc. Common Stock | $5.79M | — | $1.85 | ▼ 5.27% | $1.89$9.38 |
| BGLC BioNexus Gene Lab Corp Common stock | $3.82M | — | $1.2 | ▼ 1.64% | $1.07$5.89 |
| SERA Sera Prognostics Inc. Class A Common Stock | $78.32M | — | $2.06 | ▲ 1.48% | $1.56$3.95 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
YD Bio Partners with EG BioMed on AI Cancer Risk Tool
YD Bio Limited announced a collaboration with EG BioMed to launch an AI-based assessment tool for ten cancer risk factors. This development highlights the company's focus on integrating artificial intelligence into its diagnostic offerings. As a warrant, YDESW reflects the potential value of these strategic partnerships in the underlying stock.
YD Bio Partners with EG BioMed on AI Cancer Risk Tool. YD Bio Limited announced a collaboration with EG BioMed to launch an AI-based assessment tool for ten cancer risk factors. This development highlights the company's focus on integrating artificial intelligence into its diagnostic offerings. As a warrant, YDESW reflects the potential value of these strategic partnerships in the underlying stock.